Neoadjuvant and Adjuvant Exemestane in Treating Postmenopausal Women With Locally Advanced Hormone Receptor-Positive Breast Cancer
Status: WITHDRAWN
Study type: INTERVENTIONAL
Conditions: Stage II Breast Cancer|Stage IIIA Breast Cancer|Stage IIIB Breast Cancer|Stage IIIC Breast Cancer
Interventions: DRUG: exemestane|PROCEDURE: adjuvant therapy|PROCEDURE: aromatase inhibition|PROCEDURE: conventional surgery|PROCEDURE: endocrine therapy|PROCEDURE: hormone therapy|PROCEDURE: neoadjuvant therapy|PROCEDURE: surgery
Sponsor: Robert H. Lurie Cancer Center
Collaborators: National Cancer Institute (NCI)